Related stories
Regeneron Secures FDA Approval for Livsayis
Regeneron collaborator Alnylam reported FDA approval of Livsayis (cemdisiran).
M impact | REGULATION | Nov 19, 2026, 01:01 PM UTC
UBS CFO Says Competitiveness Impact of Too-Big-to-Fail Rules Must Be Considered
L impact | REGULATION | Nov 19, 2026, 12:45 PM UTC
UK Orders Apple to Provide Access to Data, Tribunal Says
A UK tribunal says the UK has imposed an order demanding access to Apple data.
M impact | REGULATION | Nov 19, 2026, 12:28 PM UTC
UK Tribunal Says Government Ordered Apple to Bypass Encryption
A UK tribunal says the British government has ordered Apple to bypass encryption to access customer data.
M impact | REGULATION | Nov 19, 2026, 12:26 PM UTC
FDA Grants AstraZeneca Priority Review for Sonesitatug Vedotin
The FDA accepted AstraZeneca’s biologics license application for sonesitatug vedotin and granted Priority Review for second- and l
M impact | REGULATION | Nov 19, 2026, 12:03 PM UTC
EU and Indonesia to Formally Sign Trade Deal Saturday
The EU and Indonesia are set to formally sign a previously agreed trade deal on Saturday.
L impact | REGULATION | Nov 19, 2026, 11:20 AM UTC